UGT2B15 Inhibitors

Name

UGT2B15 Inhibitors

Accession Number

DBCAT004457

Description

Not Available

Drugs

Drug	Drug Description
Eltrombopag	A thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies.
Trofinetide	A drug used to treat Rett syndrome in children and adults.

Drugs & Drug Targets

Drug	Target	Type
Eltrombopag	Thrombopoietin receptor	target
Eltrombopag	Cytochrome P450 2C8	enzyme
Eltrombopag	Cytochrome P450 1A2	enzyme
Eltrombopag	UDP-glucuronosyltransferase 1-1	enzyme
Eltrombopag	UDP-glucuronosyltransferase 1-3	enzyme
Eltrombopag	Solute carrier organic anion transporter family member 1B1	transporter
Eltrombopag	ATP-binding cassette sub-family G member 2	transporter
Eltrombopag	UDP-glucuronosyltransferase 1-9	enzyme
Trofinetide	Cytochrome P450 3A4	enzyme
Trofinetide	UDP-glucuronosyltransferase 1-9	enzyme
Trofinetide	UDP-glucuronosyltransferase 2B7	enzyme
Trofinetide	UDP-glucuronosyltransferase 2B15	enzyme
Trofinetide	Solute carrier organic anion transporter family member 1B1	transporter
Trofinetide	Solute carrier organic anion transporter family member 1B3	transporter